In summary, results from the current study provide an experimental basis for vaspin to be used as a potential insulin-sensitizing and anti-inflammatory agent for islet β cells, bringing new hope for the treatment and prevention of type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.